title: Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor.
abstract: Some medical practitioners prescribe GSH and vitamin C alone or in combination with DMPS or DMSA for patients with mercury exposure that is primarily due to the mercury vapor emitted by dental amalgams.
  
  
  OBJECTIVE
  This study tested the hypothesis that GSH, vitamin C, or lipoic acid alone or in combination with DMPS or DMSA would decrease brain mercury.
  
  
  METHODS
  Young rats were exposed to elemental mercury by individual nose cone, at the rate of 4.0 mg mercury per m3 air for 2 h per day for 7 consecutive days. After a 7-day equilibrium period, DMPS, DMSA, GSH, vitamin C, lipoic acid alone, or in combination was administered for 7 days and the brain and kidneys of the animals removed and analyzed for mercury by cold vapor atomic absorption.
  
  
  RESULTS
  None of these regimens reduced the mercury content of the brain. Although DMPS or DMSA was effective in reducing kidney mercury concentrations, GSH, vitamin C, lipoic acid alone, or in combination were not.
  
  
  CONCLUSIONS
  One must conclude that the palliative effect, if any, of GSH, vitamin C, or lipoic acid for treatment of mercury toxicity due to mercury vapor exposure does not involve mercury mobilization from the brain and kidney.
authors.affiliation: Department of Molecular and Cellular Biology, The University of Arizona, Tucson, Arizona 85721-0106, USA. aposhian@u.arizona.edu
authors.forename: H Vasken
authors.initials: HV
authors.lastname: Aposhian
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Morgan
authors.forename: H L Sam
authors.initials: HL
authors.lastname: Queen
authors.forename: Richard M
authors.initials: RM
authors.lastname: Maiorino
authors.forename: Mary M
authors.initials: MM
authors.lastname: Aposhian
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects*; D002614:Chelating Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005978:Glutathione / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects*; D008297:Male; D008630:Mercury Poisoning / Q000188:drug therapy*; D051381:Rats; D017207:Rats, Sprague-Dawley; D004113:Succimer / Q000627:therapeutic use*; D008063:Thioctic Acid / Q000627:therapeutic use*; D014494:Unithiol / Q000627:therapeutic use*; D014835:Volatilization
chemical_list: D000975:Antioxidants; D002614:Chelating Agents; D014494:Unithiol; D008063:Thioctic Acid; D004113:Succimer; D005978:Glutathione; D001205:Ascorbic Acid